Issuer Free Writing Prospectus dated June 2, 2020
Filed Pursuant to Rule 433
Relating to Preliminary Prospectus Supplement dated June 2, 2020
To Prospectus dated June 2, 2020
Registration No. 333-231720
RenaissanceRe Announces Public Offering of 5,500,000 Common Shares
Pembroke, Bermuda, June 2, 2020 RenaissanceRe Holdings Ltd. (NYSE: RNR) (the Company or
RenaissanceRe) announced today that it has commenced an underwritten public offering of 5,500,000 of its common shares.
The Company intends
to use the net proceeds from this offering for general corporate purposes, which may include expanding existing business lines, entering new business lines, forming new joint ventures, or acquiring books of business from other companies.
State Farm Mutual Automobile Insurance Company (State Farm), which currently owns approximately 4.4% of RenaissanceRes total common shares
outstanding, has entered into an investment agreement to purchase, subject to the consummation of the underwritten public offering and other customary conditions, approximately $75 million of the Companys common shares at the public
offering price per share in a concurrent private placement exempt from the registration requirements of the U.S. Securities Act of 1933, as amended.
Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC are acting as joint book-running managers and representatives of the underwriters for
the offering. The underwriters will have the option to purchase up to an aggregate of 825,000 additional common shares from the Company.
The shares are
being offered pursuant to an effective shelf registration statement that has been filed with the Securities and Exchange Commission (the SEC). This press release does not constitute an offer to sell or a solicitation of an
offer to buy nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any
offer, or solicitation to buy, if at all, will be made solely by means of a prospectus and related prospectus supplement filed with the SEC. You may obtain these documents without charge from the SEC at www.sec.gov.
Alternatively, you may request copies of these materials from Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, New York 10014, Attention: Prospectus Department, or from Goldman Sachs & Co. LLC, Attention:
Prospectus Department, 200 West Street, New York, New York 10282, telephone: 1-866-471-2526 or by emailing prospectus-ny@ny.email.gs.com.
About RenaissanceRe
RenaissanceRe is a global provider of reinsurance and insurance that specializes in matching well-structured risks with efficient sources of capital. The
Company provides property, casualty and specialty reinsurance and certain insurance solutions to customers, principally through intermediaries. Established in 1993, the Company has offices in Bermuda, Australia, Ireland, Singapore, Switzerland, the
United Kingdom and the United States.
Cautionary Statement Regarding Forward-Looking Statements
Any forward-looking statements made in this Press Release reflect RenaissanceRes current views with respect to future events and financial performance
and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are subject to numerous factors that could cause actual results to differ materially from those set forth in or implied by
such forward-looking statements, including the following: the uncertainty of the continuing impact of the COVID-19 pandemic and measures taken in response thereto; the effect of legislative, regulatory,
judicial or social influences related to the COVID-19 pandemic on the Companys financial performance, including the emergence of unexpected or un-modeled insurance
or reinsurance losses, and the Companys ability to conduct its business; the impact and potential future impacts of the COVID-19 pandemic on the value of the Companys investments and its access to
capital in the future or the pricing or terms of available financing; the effect that measures taken to mitigate the COVID-19 pandemic have on the Companys operations and those of its counterparties; the
frequency and severity of catastrophic and other events the Company covers; the effectiveness of the Companys claims and claim expense reserving process; the effect of climate change on the Companys business, including the trend towards
increasingly frequent and severe climate events; the Companys ability to maintain its financial strength ratings; the effect of emerging claims and coverage issues; collection on claimed retrocessional coverage, and new retrocessional
reinsurance being available on acceptable terms and providing the coverage that the Company intended to obtain; the Companys reliance on a small and decreasing number of reinsurance brokers and other distribution services for the preponderance
of its revenue; the Companys exposure to credit loss from counterparties in the normal course of business; the effect of continued challenging economic conditions throughout the world; the performance of the Companys investment
portfolio; a contention by the U.S. Internal Revenue Service that Renaissance Reinsurance Ltd., or any of the Companys other Bermuda subsidiaries, is subject to taxation in the U.S.; the effects of U.S. tax reform legislation and possible
future tax reform legislation and regulations, including changes to the tax treatment of the Companys shareholders or investors in its joint ventures or other entities it manages; the effect of cybersecurity risks, including technology
breaches or failure, on the Companys business; the success of any of the Companys strategic